| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98f1949cb2f8c5bbd40c7540ccd5743a |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28 |
| filingDate |
1992-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1995-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6530059f1dd78da42d306593346ffeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ab26108d61f249d9e7c7d6782d7700f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e1e4e5723096d01e48469830c163d55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81c231c776bae71f0c0dac65be3a799e |
| publicationDate |
1995-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2050020-C1 |
| titleOfInvention |
Method for modeling secondary immunodeficiency state of t- cell type |
| abstract |
FIELD: medicine. SUBSTANCE: method involves administering agglutinating pertussis serum to experimental animals at a single intraperitoneal dose of 0.10 ml. EFFECT: simplified method; improved reproducibility. 6 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2644539-C2 |
| priorityDate |
1992-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |